An integrative proteomics approach identifies tyrosine kinase KIT as a therapeutic target for SPINK1-positive prostate cancer

Nishat Manzar(Indian Institute of Technology Kanpur), Bushra Ateeq(Indian Institute of Technology Kanpur)
iScience
January 4, 2024
Cited by 9


Related Papers